我出生在福建泉州，从小在海边长大，对海洋有着深厚的感情，骨子里流淌着闽商"敢为人先、爱拼会 赢"的血液。作为中国特种水产业鳗鱼产业的见证者、参与者、推动者、收获者，我见证了行业"从无到 有，从小到大"的蜕变历程。从靠"一粒饲料走天下"起步，到现在我们以"鳗业为核心，食品为新蓝海， 饲料为主基石"产业战略定位，公司鳗鱼产业规模已跃居全球首位。 从早期定下"安全、高效、环保"作为产品属性到构建从种苗到餐桌的全流程可溯源体系，食品安全是我 们贯穿三十余年发展的核心命题。我们的产品因此畅销全球70多个国家和地区，今年我们也将活鳗出口 到韩国和日本，在日本设立分公司成立新品牌，深化了我们的全球化战略，现在中国的鳗鱼出口已经占 全球的70%。 自从天马科技（603668）上市后，我们就通过"实业+资本"的战略赋能产业发展，带动了渔民和农民的 增收，我们也将继续坚持"为了人类健康，追求卓越品质"的信念，牢牢紧扣安全、绿色、健康、美味的 产业属性，以新质产业化发展做精鳗鱼全产业链，打造世界级全产业链食品供应链平台，成为中国资本 市场乃至全球渔牧产业中一张闪亮的"价值名片"。 早期，我们国家的鳗鱼产业基础薄弱、材料不足、配套装 ...

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

证券代码：603668 证券简称：天马科技 公告编号：2025-095 福建天马科技集团股份有限公司 关于补缴税款的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 福建天马科技集团股份有限公司（以下简称"公司"）及合并报表范围内子 公司（以下简称"子公司"）近期根据税务部门的要求，对涉税事项展开自查， 现将有关情况公告如下： 一、基本情况 经自查，公司及子公司应补缴税款及滞纳金合计 536.25 万元。截至本公告 披露日，公司及子公司已按要求将上述税款及滞纳金缴纳完毕，本事项不涉及行 政处罚。 二、对公司的影响 特此公告。 福建天马科技集团股份有限公司 董 事 会 二〇二五年十二月十八日 根据《企业会计准则第 28 号——会计政策、会计估计变更和差错更正》相 关规定，上述补缴税款及滞纳金事项不属于前期会计差错，不涉及前期财务数据 追溯调整。本次补缴税款及滞纳金将计入公司 2025 年当期损益，预计将减少公 司 2025 年度归属于上市公司股东的净利润 536.25 万元，最终以 2025 年度经审 计的财务报表为准。本次 ...

格隆汇12月17日丨天马科技(603668.SH)公布，经自查，公司及子公司应补缴税款及滞纳金合计536.25万 元。截至本公告披露日，公司及子公司已按要求将上述税款及滞纳金缴纳完毕，本事项不涉及行政处 罚。 ...

Group 1 - The company reported a total eel output of approximately 1,197.15 tons for November 2025, with 219.85 tons for export and 977.30 tons for self-use [2] - The sales price range for eels in November 2025 was between 53,000 yuan/ton and 89,000 yuan/ton [2] - Cumulatively, from January to November 2025, the company produced approximately 16,415.87 tons of eels, with 8,698.67 tons for export and 7,717.20 tons for self-use [2] Group 2 - The eel output specifications primarily ranged from 1P to 5P [2] - The price fluctuations are attributed to the export of a small quantity of live Japanese eels to Japan and South Korea, which have different pricing compared to domestic sales [5] - The data provided is based on internal statistics and is unaudited, serving only as a reference for investors regarding the company's eel farming operations [6]

Core Viewpoint - Tianma Technology (603668) reported its eel output for November 2025, indicating a total of approximately 1,197.15 tons, with significant portions allocated for both export and self-use [1] Group 1: November 2025 Eel Output - The company’s eel output in November 2025 was approximately 1,197.15 tons, with 219.85 tons for export and 977.30 tons for self-use [1] - The main specifications of the eels during this month were between 1P and 5P, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [1] Group 2: Cumulative Eel Output (January to November 2025) - From January to November 2025, the company’s cumulative eel output reached approximately 16,415.87 tons, with 8,698.67 tons for export and 7,717.20 tons for self-use [1] - The specifications for the cumulative output were also primarily between 1P and 5P, with sales prices varying from 50,000 yuan/ton to 130,000 yuan/ton [1]

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

证券代码：603668 证券简称：天马科技 公告编号：2025-094 2025 年 1~11 月，公司鳗鱼累计出池约 16,415.87 吨，其中外销约 8,698.67 吨，自用约 7,717.20 吨，本期鳗鱼出池规格主要在 1P~5P 之间，销售价格区间 为 5.0 万元/吨~13.0 万元/吨。 说明：鳗鱼出池规格一般以每公斤的 P 数（尾数）为区分。 上述出池数据未经审计，与定期报告披露的数据之间可能存在差异，因此上 述数据仅作为阶段性数据供投资者参考。 | | 月份 | | 出池量（吨） | 外销数量（吨） | 自用数量（吨） | 销售价格区间 （万元/吨） | | --- | --- | --- | --- | --- | --- | --- | | 2025 | 年 1 | 月 | 902.15 | 627.70 | 274.45 | 5.2~7.7 | | 2025 | 年 2 | 月 | 1,012.28 | 730.12 | 282.16 | 5.0~8.7 | | 2025 | 年 3 | 月 | 1,295.83 | 583.05 | 712.78 | 5.0~8.7 | | 20 ...

Core Viewpoint - Tianma Technology (603668.SH) reported its eel output for November, indicating a significant production and sales performance in the eel industry [1] Group 1: November Performance - The company produced approximately 1,197.15 tons of eel in November, with external sales accounting for about 219.85 tons and self-use for approximately 977.30 tons [1] - The main specifications of the eels produced in November were between 1P-5P, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [1] Group 2: Year-to-Date Performance - From January to November, the total eel output reached approximately 16,415.87 tons, with external sales of about 8,698.67 tons and self-use of approximately 7,717.20 tons [1] - The specifications for the eels during this period were also primarily in the 1P-5P range, with sales prices varying from 50,000 yuan/ton to 130,000 yuan/ton [1]